Skip to content
Posted on
March 29, 2024
by:
fin
FDA給予生物星藥業注射型尤提隆(UTD1)罕見病資格,用於治療乳癌腦轉移,有73%的中樞神經系統總反應率!
Hong Kong PR
Posted on
March 29, 2024
by:
fin
FDA給予生物星藥業注射型尤提隆(UTD1)罕見病資格,用於治療乳癌腦轉移,有73%的中樞神經系統總反應率!
Menu
Home
SeaPRwire
ACN Newswire
JCN Newswire
EQS Newswire
Contact
Oops! That page can't be found.
It looks like nothing was found at this location. Maybe try a search?
Search for:
Search